287 related articles for article (PubMed ID: 8262321)
1. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
[TBL] [Abstract][Full Text] [Related]
4. Islet cell antibodies in patients with autoimmune thyroid disease.
Yamaguchi Y; Chikuba N; Ueda Y; Yamamoto H; Yamasaki H; Nakanishi T; Akazawa S; Nagataki S
Diabetes; 1991 Mar; 40(3):319-22. PubMed ID: 1999272
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies.
Kawasaki E; Abiru N; Yano M; Uotani S; Matsumoto K; Matsuo H; Yamasaki H; Yamamoto H; Yamaguchi Y; Akazawa S
J Autoimmun; 1995 Oct; 8(5):633-43. PubMed ID: 8579720
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65.
Akamine H; Komiya I; Shimabukuro T; Asawa T; Tanaka H; Yagi N; Taira T; Nagata K; Arakaki K; Wakugami T; Takasu N; Powell MJ; Furmaniak J; Smith BR
Diabet Med; 1997 Sep; 14(9):778-84. PubMed ID: 9300229
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to 64,000-M(r) islet cell protein in long-term type 1 (insulin-dependent) diabetic patients.
Kawasaki E; Moriuchi R; Takino H; Okuno S; Takao Y; Maeda Y; Yokota A; Yamamoto H; Chikuba N; Akazawa S
Diabetologia; 1992 Aug; 35(8):748-52. PubMed ID: 1511801
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity.
Moriguchi M; Noso S; Kawabata Y; Yamauchi T; Harada T; Komaki K; Babaya N; Hiromine Y; Ito H; Yamagata S; Murata K; Higashimoto T; Park C; Yamamoto A; Ohno Y; Ikegami H
Metabolism; 2011 Jun; 60(6):761-6. PubMed ID: 20825955
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
[TBL] [Abstract][Full Text] [Related]
15. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
DeAizpurua HJ; Honeyman MC; Harrison LC
J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
[TBL] [Abstract][Full Text] [Related]
16. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
[TBL] [Abstract][Full Text] [Related]
20. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]